# Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

> **NCT00317486** · PHASE4 · COMPLETED · sponsor: **Actelion** · enrollment: 54 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

## Interventions

- **DRUG:** bosentan

## Key facts

- **NCT ID:** NCT00317486
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2005-04
- **Final completion:** 2005-04
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317486, "Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00317486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*